| Targeting SARS-CoV-2 main protease for treatment of COVID-19: Covalent inhibitors structure–activity relationship insights and evolution perspectives G La Monica, A Bono, A Lauria, A Martorana Journal of medicinal chemistry 65 (19), 12500-12534, 2022 | 104 | 2022 |
| Quinoline anticancer agents active on DNA and DNA-interacting proteins: From classical to emerging therapeutic targets A Lauria, G La Monica, A Bono, A Martorana European Journal of Medicinal Chemistry 220, 113555, 2021 | 69 | 2021 |
| Antiproliferative activity predictor: a new reliable in silico tool for drug response prediction against NCI60 panel A Martorana, G La Monica, A Bono, S Mannino, S Buscemi, ... International Journal of Molecular Sciences 23 (22), 14374, 2022 | 9 | 2022 |
| Off-target-based design of selective hiv-1 protease inhibitors G La Monica, A Lauria, A Bono, A Martorana International Journal of Molecular Sciences 22 (11), 6070, 2021 | 9 | 2021 |
| mai n protease for treatment of COVID-19: covalent inhibitors structure–activit y relationship insights and evolution perspectives G La Monica, A Bono, A Lauria, A Martorana J. Med. Chem 65, 12500-12534, 2022 | 8 | 2022 |
| In silico mixed ligand/structure-based design of new CDK-1/PARP-1 dual inhibitors as anti-breast cancer agents A Bono, G La Monica, F Alamia, F Mingoia, C Gentile, D Peri, A Lauria, ... International Journal of Molecular Sciences 24 (18), 13769, 2023 | 6 | 2023 |
| In Silico Design of New Dual Inhibitors of SARS-CoV-2 MPRO through Ligand- and Structure-Based Methods A Bono, A Lauria, G La Monica, F Alamia, F Mingoia, A Martorana International Journal of Molecular Sciences 24 (9), 8377, 2023 | 6 | 2023 |
| Synthesis of new antiproliferative 1, 3, 4-substituted-pyrrolo [3, 2-c] quinoline derivatives, biological and in silico insights F Mingoia, C Di Sano, C D'Anna, M Fazzari, L Minafra, A Bono, ... European Journal of Medicinal Chemistry 258, 115537, 2023 | 5 | 2023 |
| Bioisosteric heterocyclic analogues of natural bioactive flavonoids by scaffold-hopping approaches: State-of-the-art and perspectives in medicinal chemistry G La Monica, A Bono, F Alamia, A Lauria, A Martorana Bioorganic & Medicinal Chemistry, 117791, 2024 | 4 | 2024 |
| Design and Synthesis of Novel Thieno[3,2-c]quinoline Compounds with Antiproliferative Activity on RET-Dependent Medullary Thyroid Cancer Cells G La Monica, G Pizzolanti, C Baiamonte, A Bono, F Alamia, F Mingoia, ... ACS omega 8 (38), 34640-34649, 2023 | 3 | 2023 |
| Scaffold-hopping strategies in aurone optimization: A comprehensive review of synthetic procedures and biological activities of nitrogen and sulfur analogues G La Monica, F Alamia, A Bono, A Lauria, A Martorana Molecules 29 (12), 2813, 2024 | 2 | 2024 |
| One pot-like regiospecific access to 1-aryl-1H-pyrazol-3 (2H)-one derivatives and evaluation of the anticancer activity F Mingoia, G Panzeca, MC Vitale, G La Monica, A Bono, A Lauria, ... Arkivoc 2022, 191-203, 2022 | 2 | 2022 |
| Antiproliferative properties and g-quadruplex-binding of symmetrical naphtho [1, 2-b: 8, 7-b’] dithiophene derivatives A Lauria, G La Monica, A Terenzi, G Mannino, R Bonsignore, A Bono, ... Molecules 26 (14), 4309, 2021 | 2 | 2021 |
| A novel in silico approach for identifying multi-target JAK/STAT inhibitors as anticancer agents A Bono, G La Monica, F Alamia, A Lauria, A Martorana Journal of Molecular Graphics and Modelling 135, 108913, 2025 | | 2025 |
| Design, Synthesis, and In Silico Insights of new 4‐Piperazinylquinolines as Antiproliferative Agents against NCI Renal Cancer Cell Lines G La Monica, A Bono, F Alamia, A Martorana, A Lauria ChemistryOpen, e202400518, 2025 | | 2025 |
| Novel Antibacterial 4-Piperazinylquinoline Hybrid Derivatives Against Staphylococcus aureus: Design, Synthesis, and In Vitro and In Silico Insights G La Monica, A Gallo, A Bono, F Alamia, A Lauria, R Alduina, A Martorana Molecules 30 (1), 28, 2024 | | 2024 |
| In Silico Design of Dual Estrogen Receptor and Hsp90 Inhibitors for ER-Positive Breast Cancer Through a Mixed Ligand/Structure-Based Approach G La Monica, F Alamia, A Bono, F Mingoia, A Martorana, A Lauria Molecules 29 (24), 6040, 2024 | | 2024 |
| Targeting the SARS-CoV-2 MPRO through covalent and non-covalent inhibition: molecular modeling and synthetic procedures for the development of new antiviral molecules A Bono Università degli Studi di Palermo, 2024 | | 2024 |
| Innovative In Silico Method for Discovering Multi-Target JAK/STAT Inhibitors as Potential Anticancer Therapies A Bono, G LA MONICA, F Alamia, A Lauria, A Martorana Atti del Congresso Congiunto 2024 delle Sezioni Sicilia e Calabria della …, 2024 | | 2024 |
| Machine learning model for predicting molecular activity using Molecular Descriptors and ElectroShape Descriptors-FL051 A Bono, A Asad, M Albanese, RI Cooper, A Lauria, G LA MONICA, ... Proceedings of the Merck Young Chemists’ Symposium XXIII edition, 2024 | | 2024 |
Antonino LauriaProfessore Ordinario, Università di PalermoEmail verificata su unipa.it